7TN

Iguratimod

Created:	2021-08-20
Last modified:	2024-05-01

Find Related PDB Entry
1 entries where 7TN is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	40
Chiral Atom Count	0
Bond Count	42
Aromatic Bond Count	12

2D diagram of 7TN

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Iguratimod
Synonyms	T 614; T-614; T614; N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide; Careram; Kolbet
Systematic Name (OpenEye OEToolkits)	~{N}-[7-(methylsulfonylamino)-4-oxidanylidene-6-phenoxy-chromen-3-yl]methanamide
Formula	C₁₇ H₁₄ N₂ O₆ S
Molecular Weight	374.368
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CS(=O)(=O)Nc1cc2OC=C(NC=O)C(=O)c2cc1Oc1ccccc1
SMILES	CACTVS	3.385	C[S](=O)(=O)Nc1cc2OC=C(NC=O)C(=O)c2cc1Oc3ccccc3
SMILES	OpenEye OEToolkits	2.0.7	CS(=O)(=O)Nc1cc2c(cc1Oc3ccccc3)C(=O)C(=CO2)NC=O
Canonical SMILES	CACTVS	3.385	C[S](=O)(=O)Nc1cc2OC=C(NC=O)C(=O)c2cc1Oc3ccccc3
Canonical SMILES	OpenEye OEToolkits	2.0.7	CS(=O)(=O)Nc1cc2c(cc1Oc3ccccc3)C(=O)C(=CO2)NC=O
InChI	InChI	1.06	InChI=1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20)
InChIKey	InChI	1.06	ANMATWQYLIFGOK-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB12233
Name	Iguratimod
Groups	investigational
Description	Iguratimod is under investigation in Rheumatoid Arthritis.
Synonyms	Iguratimod
Categories	Amides Benzopyrans Heterocyclic Compounds, Fused-Ring Pyrans Sulfones Sulfur Compounds
CAS number	123663-49-0

Related Resource References

Resource Name	Reference
PubChem	124246
ChEMBL	CHEMBL2107455
ChEBI	CHEBI:31689
COD	8107499

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.